Northwire Canada EditionSunday, July 12, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Healthcare

Page 16
  1. May 20, 2026 · 17:07 · CTX · Routine +

    Crescita Therapeutics Secures Final Court Approval for ClinActiv Acquisition; Shares Trade Near Offer Price

    Crescita Therapeutics Inc. Obtains Final Order Approving Plan of Arrangement

    01
  2. May 20, 2026 · 11:07 · TLT · Routine +

    Theralase Secures Runway for Q3 Regulatory Filing Amidst Dilution Concerns

    Theralase(R) Closes C$4.8 Million Offering

    02
  3. May 20, 2026 · 07:45 · RVV · Routine +

    Revive Therapeutics Patents Fuel Defense Strategy Amidst Price Consolidation

    Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures

    03
  4. May 20, 2026 · 07:00 · GREY · Routine +

    Grey Matters Health Signs LOI for Tampa Trial, Yet Dilution and Timeline Risks Persist

    Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer's Clinical Trial at 2nd NovaScan Location Planned for Tampa

    04
  5. May 20, 2026 · 06:55 · AVCR · Routine −

    Avricore Health Raises $1.25M Amidst UK Expansion Push; Dilution Concerns Loom

    Avricore Health Announces $1.25 Million Financing

    05
  6. May 19, 2026 · 19:36 · PREV · Routine −

    PreveCeutical Extends Financing Deadline Amidst Liquidity Concerns

    PreveCeutical Announces Extension of Non-Brokered Private Placement

    06
  7. May 19, 2026 · 18:00 · ONCO · Routine −

    CMC Progress Ignored as Dilution Fears Drive Stock to Near-Zero Valuation

    Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program

    07
  8. May 19, 2026 · 17:16 · RVX · Routine +

    Resverlogix Settles Debt via Equity Dilution Amidst Regulatory Filing Delays

    Resverlogix Closes US$2 Million Shares-for-Interest Private Placement

    08
  9. May 19, 2026 · 16:04 · NRX · Routine +

    NurExone Expands IP Portfolio with South Korea Patent Grant Amidst Manufacturing Push

    NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology

    09
  10. May 19, 2026 · 09:52 · RX · Material +

    BioSyent enters endocrinology with sole-source liquid levothyroxine — a niche launch, but the upside hinges on Tibella/FeraMAX still doing the heavy lifting.

    BioSyent Announces Health Canada Approval of Thyconvi(TM) (levothyroxine oral solution)

    10
  11. May 19, 2026 · 08:30 · SEGN · Routine +

    Seegnal Eyes U.S. Expansion Amid Regulatory Filing Overhang

    Seegnal Announces Letter of Intent with U.S.-Based Care Facility, Marking First Penetration of the American Healthcare Market

    11
  12. May 19, 2026 · 07:01 · WELL · Routine +

    WELL Health Renews Share Buyback Amidst Strong Earnings Growth and Strategic Spin-Out Plans

    WELL Health Announces Approval of Normal Course Issuer Bid

    12
  13. May 19, 2026 · 07:01 · BPC · Routine +

    Precision Peptide Clears Purity Hurdle, But Commercial Execution Risks Remain

    The Precision Peptide Company (BPC) Lead Product Achieves 95.5% Purity in Independent Lab Testing, Clearing the Industry Benchmark and Advancing Toward Commercial Launch

    13
  14. May 19, 2026 · 07:00 · XRTX · Routine −

    XORTX closes deep-discount offering with half the proceeds going to investor relations, signaling potential desperation and further dilution ahead.

    XORTX Announces Closing of US$5 Million Public Offering

    14
← Newer Older →